Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07215767 · ClinicalTrials.gov registry record · Phase 3

Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice

A Phase 3 study of Dentin Hypersensitivity, sponsored by HALEON.

Recruiting
Registry status
Phase 3
Development phase
850
Enrollment target
3
Study locations

NCT07215767 is a Phase 3 study of Dentin Hypersensitivity that is actively recruiting participants, run by HALEON. The registered enrollment target is 850 participants, above the 175-participant average among 4 other Dentin Hypersensitivity trials with a reported enrollment target (386% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07215767, a Phase 3 study of Dentin Hypersensitivity, is actively recruiting participants, sponsored by HALEON.

RECRUITING
Registry status
Phase 3
Development phase
850 participants
Enrollment target
3
Study locations

Study Summary

The aim of this clinical study is to demonstrate the superior antihypersensitivity efficacy of a novel stannous fluoride (SnF2) and potassium nitrate (KNO3) dentifrice (Investigational Product), compared to SnF2 only, KNO3 only and Vehicle dentifrices, after 8 weeks twice daily use.

Conditions Studied

Dentin Hypersensitivity

Interventions

  • DRUG Stannous fluoride and Potassium nitrate Dentifrice
  • DRUG Stannous fluoride Dentifrice
  • DRUG Potassium nitrate Dentifrice
  • DRUG Vehicle Dentifrice

Study Locations (3)

Florida

  • All Sum Research Limited - Melbourne

Indiana

  • Salus Research, Inc. - Fort Wayne

Nevada

  • Silverstone Research - Las Vegas

Trial Details

FieldValue
Enrollment Target 850 participants
Start Date 2025-09-16
Est. Completion 2026-08
Phase Phase 3

Sponsor

HALEON

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07215767

The ClinicalTrials.gov registry entry for NCT07215767 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 850 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 175-participant average among 4 other Dentin Hypersensitivity trials with a reported enrollment target (386% higher). The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dentin Hypersensitivity appearing as the primary indexed condition, and to 4 interventions - of which Stannous fluoride and Potassium nitrate Dentifrice is the first listed.

NCT07215767 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Indiana, Nevada.

Frequently Asked Questions

What is clinical trial NCT07215767 about?

NCT07215767 is a clinical study titled "Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice". The aim of this clinical study is to demonstrate the superior antihypersensitivity efficacy of a novel stannous fluoride (SnF2) and potassium nitrate (KNO3) dentifrice (Investigational Product), compared to SnF2 only, KNO3 only and Vehicle dentifrices, after 8 weeks twice daily use.

What is the current status of trial NCT07215767?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 850 participants. The study started on 2025-09-16. Estimated completion is 2026-08.

What conditions does trial NCT07215767 study?

This clinical trial studies the following conditions: Dentin Hypersensitivity.

What interventions are being tested in trial NCT07215767?

The interventions under investigation include: Stannous fluoride and Potassium nitrate Dentifrice (DRUG), Stannous fluoride Dentifrice (DRUG), Potassium nitrate Dentifrice (DRUG), Vehicle Dentifrice (DRUG).

Who is sponsoring clinical trial NCT07215767?

This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07215767 being conducted?

This trial has 3 study locations across Florida, Indiana, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dentin Hypersensitivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dentin Hypersensitivity

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.